José Antonio García Erce: Situation of Immunoglobulins in Spain
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared a post on LinkedIn about a recent article by Pierre Tiberghien et al, published in Vox Sanguinis:
”Situation of immunoglobulins in Spain.
Is there a lack of transparency or interest on the part of the authorites? (Part 2)
In 2023, in December, Europe included Inmunoglobulinas Anti -D (Ig ) in the list of fármacos críticos (Union list of critical medicines – version 2.1 (revision January 2026) [J06BB01 human anti – D immunoglobulin] along with the rest of the hemoderivados plasmáticos.
On October 2024, a brief survey was launched from the European Blood Alliance to all member countries to ‘learn about the current situation of anti-D plasma collection and explore the possibilities of implementing programs of this type in Europe’.
The results have been included in a recent paper published by the European Committee on Blood Transfusion (CD-P-TS) of the European Directorate for the Quality of Medicines and HealthCare (EDQM), Council of Europe entitled ‘Can we have European anti – D plasma collection programes?‘
A total of 23 responses were received from 19 countries: ‘None of the countries surveyed had an active national anti-D plasma collection programme.’ Unfortunately there was no response from Spain. ¿?
On July 4, 2025, the European Medicine Agency (EMA) published an important document dated June 23: ‘Strengthening supply chain of anti-D immunoglobulins.’
‘Recommendations of the Executive Steering Group on Drug Shortages and Safety to Address Anti-D Immunoglobulin Supply Chain Vulnerabilities.’
Where they include three blocks of recommendations:
- for member states
- for the European Commission
- for the plasma industry and ‘relevant’ research organizations.
I miss that the Scientific Societies involved are included, such as the European Hematology Association (EHA), the FIGO (International Federation of Gynecology and Obstetrics) and the International Society of Blood Transfusion (ISBT).
Once again I wonder, why does the Ministry of Health and Consumer Affairs
General Directorate of Public Health. Subdirectorate General of Health Promotion and Epidemiology, as a member of the European Blood Alliance did not answer the survey?
Is it not of interest or is there no concern?
When the front page of the European Blood Alliance website since March 25 includes this headline: ‘Securing the future of anti – D immunoprophylaxis in Europe’ ”
Title: Achieving sustainable anti-D immunoprophylaxis in Europe
Authors: Pierre Tiberghien, Dragoslav Domanović, Richard Forde, Peter O’Leary, Joanne Verweij, C. Ellen van der Schoot
Reaf the Full Article on Vox Sanguinis
Stay updated with Hemostasis Today.
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center
-
May 29, 2026, 17:20Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
-
May 29, 2026, 17:18Nina Lansbury: Supporting a Period Friendly World With Menstrual Health Research and Education
-
May 29, 2026, 17:16Ipsita Chatterjee: Red is Not Shame, Red is Power, Red is a Woman
-
May 29, 2026, 16:49Abdulrahman Nasiri: The Evolving Role of Romiplostim in SAA
-
May 29, 2026, 16:46Soumen Bhattacharya: UC-II and Immune Modulation in Osteoarthritis
-
May 29, 2026, 16:38Ana Pedrero Gil: Red Blood Cell Transfusion Practice in Spain – High Inappropriateness Despite Low Overall Use
-
May 29, 2026, 15:40Lena Volland: Expanding Holistic Care in Bleeding Disorders Through Pelvic Health Physical Therapy at WFH Congress